|
Volumn 89, Issue 2, 2000, Pages 383-390
|
Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes
a a a a a a |
Author keywords
Apoptosis; BRCA1; Cell proliferation; ERBB 2; Hereditary; Morphology; Ovarian carcinoma; Ovary; P53; Premalignant
|
Indexed keywords
BRCA1 PROTEIN;
CELL PROTEIN;
KI 67 ANTIGEN;
PROTEIN P53;
ADULT;
AGED;
APOPTOSIS;
ARTICLE;
CANCER PREVENTION;
CANCER SUSCEPTIBILITY;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
EARLY DIAGNOSIS;
FEMALE;
HETEROZYGOTE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
OVARIECTOMY;
OVARY CARCINOMA;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
ADULT;
AGED;
APOPTOSIS;
BRCA1 PROTEIN;
CELL DEATH;
CELL DIVISION;
FEMALE;
GENE EXPRESSION;
GENES, BRCA1;
GERM-LINE MUTATION;
HETEROZYGOTE;
HUMAN;
KI-67 ANTIGEN;
MIDDLE AGE;
OVARIAN NEOPLASMS;
OVARIECTOMY;
OVARY;
PRECANCEROUS CONDITIONS;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
|
EID: 0034661872
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T Document Type: Article |
Times cited : (94)
|
References (28)
|